| Tag | Content |
|---|
EnhancerAtlas ID | HS109-15211 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr3:40664930-40665820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF4 | MA0039.3 | chr3:40665335-40665346 | CCACACCCTCT | + | 6.02 | | MEF2A | MA0052.3 | chr3:40665200-40665212 | GCTATAAATAGC | + | 6.32 | | MEF2B | MA0660.1 | chr3:40665200-40665212 | GCTATAAATAGC | + | 7.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10708 | chr3:40664352-40667985 | CD19_Primary | | SE_11768 | chr3:40663906-40668485 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I040623 | chr3 | 40664645 | 40667157 |
|
Enhancer Sequence | ACACACATTT TCTGTTTTCT GGCAGCCCAA CACCTCATGG GAAGGTCTGG CTTGTAGTTT 60
AACTGATGGT GTATAGTAGG TGCTCAGTTG CCTGTTTGGT CCTTTCTCTC TTCTTGATCA 120
CCCCTTTCCT CTCTGGCTCC CACATATGGT TCAAAACCTG AACACACACA TTGGCCTGCT 180
CCTCTTCTGG CTCACAAGAG AAATGAATTG GCTGGCAGGA GACCAGTATC CACCTGATGA 240
AGCAATAAAC CATGTGGCAT GTAGATATTG GCTATAAATA GCTTCCCTTC ATTATCTCCT 300
CACTCAAAGC CCTTGCCTTT GAGTACCACG TCATCCCTTG GTGCTGACAC ACCCAAACCA 360
AAGCCAGTCT CCCTAGCAAC TGAACCACAG TCAGTGGTGG TCTGACCACA CCCTCTCATG 420
GTTGGCAACC ATGCACAGTT CCTCATTTTA TTTCTGCTGC AGGACAGGTT GGCTACTGGC 480
TGATCTTTGG AACTAGAAAC ATCATTTTGC TCCTTAAATG ATTAAAAAAG GCACACATGG 540
GGCTTCTTTG TGTTAGTTCT TTTGTATCTC CATATCCTGT CCCTGCATGG ATTATTTTGG 600
TGCATGCTGC AGACTTGTTT TTGGAACTTG AATCCTGAGC AAGTGAGAAG ACTTACTGGA 660
TGCTGTTCAA GGCTCTGCAT GACAAACCTT GCACAAATAC AAGGTATGAT TGCCACTGAC 720
AGGGAGGATC ATGAGCTAGC TGGGATGTAG GGAAAGATCA GGTGGCAAAG GTGTTTCAGG 780
TGCAGGTGTA TCTTGCCCAG GGTGCCCACC TCAGCAAGTG ATAACAAAGG CTAGAGTTAC 840
AGTGCTAGGC CCTGGACTTA GACTGGGGAG ACAAGGACAG GATGATCACA 890
|
